Furue Akiko, Honda Masako, Hattori Kyoko, Sato Erina, Yamashita Atsushi, Osada Mayuko, Hosono Kanako, Kamata Mariko, Ito Yoshiya, Shibuya Masabumi, Kato Kazuyoshi, Amano Hideki
Department of Pharmacology, Kitasato University School of Medicine, Sagamihara, Japan.
Department of Molecular Pharmacology, Graduate School of Medical Sciences, Kitasato University, Sagamihara, Japan.
In Vivo. 2025 Sep-Oct;39(5):2584-2598. doi: 10.21873/invivo.14059.
BACKGROUND/AIM: Endometriosis is characterized by the accumulation of immune cells in endometrial lesions and the peritoneal cavity. Macrophages contribute to the growth and neovascularization of endometriotic lesions. Vascular endothelial growth factor receptor-1 (VEGFR1) is involved in neovascularization, while peritoneal macrophages (PMs) play a critical role in endometriosis development and establishment. We examined the role of VEGFR1 signaling in PMs during endometriosis development using a murine model of ectopic endometrial transplantation.
Endometrial fragments from female wild-type (WT) or VEGFR1 tyrosine kinase-deficient (TK) donor mice were implanted into the peritoneal walls of recipient mice, either in a WT→WT or TK→TK combination. On day 14 after endometrial transplantation, the implant size, neovascular growth-promoting factors, macrophage accumulation in the implants and peritoneal cavity, and cytokine production were assessed. PMs from WT or TK mice were transferred into the peritoneal cavity of WT→WT mice and their effects were assessed.
Compared to WT→WT mice, TK→TK mice exhibited smaller implant sizes and reduced neovascularization, including angiogenesis and lymphangiogenesis. This was correlated with an increase in pro-inflammatory (M1) and a decrease in alternative (M2) large peritoneal macrophages (LPMs) within the peritoneal cavity. Transfer of TK-PMs into the peritoneal cavity of WT→WT mice reduced endometriosis development and macrophage accumulation. This led to increased expression of M1 macrophage genes and decreased expression of M2 phenotype genes, compared to WT-PMs transfer. PMs from TK mice exhibited increased M1-related and decreased M2-related gene expression.
Deletion of VEGFR1 TK signaling in PMs suppressed endometriosis progression and neovascularization by increasing M1 LPMs. Specific inactivation of VEGFR1 TK signaling may represent a potential therapeutic target for the management of endometriosis.
背景/目的:子宫内膜异位症的特征是免疫细胞在子宫内膜病变和腹腔中积聚。巨噬细胞有助于子宫内膜异位症病变的生长和新生血管形成。血管内皮生长因子受体-1(VEGFR1)参与新生血管形成,而腹腔巨噬细胞(PMs)在子宫内膜异位症的发生和发展中起关键作用。我们使用异位子宫内膜移植小鼠模型研究了VEGFR1信号在子宫内膜异位症发展过程中PMs中的作用。
将雌性野生型(WT)或VEGFR1酪氨酸激酶缺陷型(TK)供体小鼠的子宫内膜碎片植入受体小鼠的腹膜壁,采用WT→WT或TK→TK组合。在子宫内膜移植后第14天,评估植入物大小、促新生血管生长因子、植入物和腹腔内巨噬细胞积聚以及细胞因子产生情况。将WT或TK小鼠的PMs转移到WT→WT小鼠的腹腔中并评估其作用。
与WT→WT小鼠相比,TK→TK小鼠的植入物尺寸更小,新生血管形成减少,包括血管生成和淋巴管生成。这与腹腔内促炎(M1)型大腹腔巨噬细胞(LPMs)增加和替代(M2)型减少有关。将TK-PMs转移到WT→WT小鼠的腹腔中可减少子宫内膜异位症的发展和巨噬细胞积聚。与WT-PMs转移相比,这导致M1巨噬细胞基因表达增加,M2表型基因表达减少。TK小鼠的PMs表现出M1相关基因表达增加,M2相关基因表达减少。
PMs中VEGFR1酪氨酸激酶信号的缺失通过增加M1 LPMs抑制了子宫内膜异位症的进展和新生血管形成。VEGFR1酪氨酸激酶信号的特异性失活可能是治疗子宫内膜异位症的潜在靶点。